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Abstract
Host IFNL4 haplotype status contributes to the development of chronic hepatitis C virus (HCV) infection in individuals who are 
acutely infected with the virus. In silico studies revealed that specific amino acid variants at multiple sites on the HCV polypro-
tein correlate with functional single- nucleotide polymorphisms (SNPs) in the IFNL4 locus. Thus, SNPs at the IFNL4 locus may 
select variants that influence virus replication and thereby the outcome of infection. Here, we examine the most significantly 
IFNL4- associated amino acid variants that lie in the ‘lambda (L) 2 loop’ of the HCV NS5B RNA polymerase. L2 loop variants were 
introduced into both sub- genomic replicon and full- length infectious clones of HCV and viral replication was examined in the 
presence and absence of exogenous IFNλ4. Our data demonstrate that while mutation of the NS5B L2 loop affects replication, 
individual IFNL4- associated variants have modest but consistent effects on replication in both the presence and absence of 
IFNλ4. Given the strong genetic association between these variants and IFNL4, these data suggest a nuanced effect of each 
individual position on viral replication, the combined effect of which might mediate resistance to the effects of IFNλ4.
Clearance of hepatitis C virus (HCV) is associated with 
genetic and functional variation in the human IFN lambda 
4 (IFNL4) gene [1]. Recent analyses of unbiased ‘genome- to- 
genome’ variant association has also identified correlations 
between HCV genetic polymorphisms at specific sites across 
the virus genome and IFNL4 variation [2–4]. This suggests 
that virus populations in those producing functional IFNL4 
differ from those generating the non- functional or less 
potent forms of the protein. Thus, there may be an interac-
tion between host and viral genetic variants that ultimately 
affects viral chronicity. A previous report characterized one 
variant in NS5A, which was linked to serum viral load in 
individuals expressing functional IFNL4, indicating that 
this IFNL4- associated site may affect virus replication in the 
sub- genomic replicon (SGR) system [2]. However, studies 
on robust full- length HCV cell culture (HCVcc) infectious 
systems have not been carried out. Furthermore, the most 
significant IFNL4- associated variant (A150V) in the NS5B 
protein from studies on HCV gt3a sequences has not been 
examined in detail for any contribution to the viral replication 
process in such systems [2–4].
The region encompassing A150V and an additional cluster 
of IFNL4- associated variants is located between amino 
acids (aa) aa2567 to aa2576 in the HCV polyprotein and lies 
towards the N- terminus of the virus- encoded NS5B RNA- 
dependent RNA polymerase (RdRp; positions 2567, 2568, 
2570 and 2576 correspond to residues 147, 148, 150 and 156 
in NS5B; Fig.  1a). This region corresponds to a relatively 
variable segment termed ‘motif F’ in the N- terminal ‘fingers’ 
domain of conserved viral RdRp enzymes of RNA viruses, 
and has been termed the lambda (L) 2 loop (Fig. 1a, b) [5, 6]. 
Comparison of HCV RdRp sequences across other families 
in the Flaviviridae, including the flaviviruses, pegiviruses and 
pestiviruses, revealed invariant amino acid residues flanking 
the L2 loop in regions termed F1 and F2. Upstream of the L2 
loop is a conserved KXE motif (X=N/K/R depending on the 
virus family), while in the downstream region are invariant 
lysine, arginine and isoleucine residues in a KXXRXI motif 
(Fig. 1b). Within the L2 loop there were no invariant residues. 
Sequence comparison of amino acid sequences for the L2 loop 
among and within HCV genotypes further demonstrated 
the variability of this region (Fig. 1c). Positions 148 and 150 
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of sequence identity at positions 146 and 154. In addition, the 
proline residue in the F2 region displayed some intergenotype 
diversity. Based on the crystal structure of HCV NS5B, the 
L2 loop corresponds to a flexible surface- exposed loop in the 
closed conformation of the protein where it extends outwards 
and over the nucleotide tunnel (Fig. 1d, e) [6]. Amino acids 
at positions 148 and 150 with the greatest variability lie at the 
extremity of the loop.
Based on the above analyses, we constructed four SGR 
and HCVcc L2 loop mutants in a JFH1 gt2a SGR construct 
containing a GLuc reporter and the Jc1 HCVcc infectious 
clone [7, 8]. We chose to utilize the JFH1/Jc1 system because 
the documented IFNL4- associated variable position 150 is 
found not only in gt3a but also in gt2 sequences. Therefore we 
were able to exploit the high replication capability of the well- 
characterized JFH1/Jc1 system. Our strategy was to create 
substitutions at positions 148 (D148A), 150 (A150V) and a 
double substitution at positions 148 and 150 (D148Q.A150E), 
thereby reconstituting the gt1a sequences at these positions 
(Fig. 1c). Gt1a is considered to be a relatively IFN- resistant 
Fig. 1. Location of IFNL4- associated positions in the L2 loop of HCV NS5B RNA polymerase. (a) Schematic of the 3’ end of the HCV genome 
showing the location of the NS5B motif F/L2 loop. (b, c) Amino acid alignment of the region encompassing motif F in the Flaviviridae 
(b) and in HCV reference sequences (selected to highlight sequence diversity) for genotypes 1–8 (c). IFNL4- associated positions 
are highlighted in bold in HCV reference sequences [for gt1a and gt2a in (b) and gt1a in (c)]. Invariant (*), conserved (:) and partially 
conserved (.) positions are highlighted directly above the alignment. Secondary structural elements in the HCV NS5B RNA polymerase 
are indicated above sequences (>> for β-strands for F1 and F2; -- for the non- structured L2 loop). HCV gt2a JFH1: AB047639.1; HCV 
gt1a H77: AF009606.1; human pegivirus 1: BAA19580.1; simian pegivirus/GB- virus A: AHH32939.1; dengue virus serotype 1 (DENV-1): 
QFS19562.1; Kyasanur Forest disease virus (KFDV): AXB87737.1; bovine viral diarrhoeal virus (BVDV): AAF82566.1; classical swine fever 
virus (CSFV): AYE19937.1. HCV subtype accession numbers are as follows: 1a_AF009606, 1 l_KC248193, 2a_D00944, 2a_AB047639, 
2a_HQ639944, 3a_D17763, 3a_JN714194, 4a_Y11604, 4 g_FJ462432, 5a_AF064490, 6a_Y12083, 7a_EF108306, 7_KU861171.1, 8_pt1 
MH590698.1, 8_pt2 MH590699.1 and 8_pt4 MH590701.1. (d, e) Structure of the L2 loop region in the HCV NS5B RNA polymerase. IFNL4- 
associated positions are shown with amino acid side- chains on the 4wti pdb structure of HCV gt2a JFH1 NS5B. The L2 loop is shown 
relative to the NTP channel and residue A150 (d) and IFNL4- associated positions are indicated in a higher magnification image (e).
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HCV subtype and these positions have been implicated in this 
phenotype as well as being associated with the IFNL4/IL28B 
genotype [9]. We also constructed a P156A variant, identified 
as being associated with the IFNL4 genotype in four HCV 
subtypes [2–4] to determine whether altering this position 
in the F2 region created a functional defect that would affect 
replication. Briefly the NS5B- coding region was sub- cloned 
into a plasmid vector and site- directed mutagenesis was used 
to alter residues before transferring the mutated fragments 
into the SGR plasmid and then into HCVcc plasmids. The 
mutagenesis primers used are available on request. All muta-
tions in the final constructs were confirmed by sequencing.
RNA from the SGR constructs was generated by in vitro 
transcription (IVT) using the manufacturer’s instructions (T7 
RiboMAX, Promega, UK) and transfected (200 ng) into sub- 
confluent monolayers of Huh7 cells in 96- well plates using 
Lipofectamine 2000 (1 µl µg−1 RNA) using the manufacturer’s 
instructions (Thermo Fisher Scientific, UK). GLuc activity in 
5 % of the supernatant (10 µl) was assessed at 4, 24, 48 and 72 h 
post- transfection using the manufacturer’s instructions. The 
reporter activity for each construct was compared to that for 
a replication- defective ‘GND’ mutant (Fig. 2a). Each of the 
mutant constructs plateaued around 48 h post- transfection 
and reached peak activity by 72 h, achieving levels that were 
not significantly different from those of the wild- type (WT) 
construct. However, we noted that D148A gave 10- fold lower 
luciferase activity at 24 and 48 h post- transfection. Both the 
double mutant D148Q.A150E and A150V constructs also 
yielded less activity than the WT (~fivefold and ~twofold, 
respectively) at earlier times post- transfection.
The same four mutants were introduced into the Jc1 HCVcc 
system to allow analysis of viral multicycle replication. 
Following IVT of HCVcc RNA and electroporation into Huh7 
cells, virus- containing supernatants were harvested at least 
3 days later and infectivity was titrated by TCID50 using an 
NS5A- specific antibody [10]. All RNAs produced infectious 
virus, although D148A yielded ~100- fold fewer infectious 
progeny (Fig.  2b). Sequences of the mutated versions of 
HCVcc were confirmed by Sanger sequencing of RT- PCR 
amplicons; no changes at the consensus level were found 
apart from D148A, which failed to yield an RT- PCR product, 
presumably due to reduced replication of viral RNA (data 
not shown). Assessment of HCVcc RNA accumulation at 
72 h post- infection following infection of Huh7 cells infected 
at a multiplicity of infection (m.o.i.) of 0.01 showed that while 
HCVcc viral RNA was detected by RT- qPCR as described 
previously [7] in all infections, only D148A and D148Q.
A150E showed major differences (Fig. 2b). D148A gave a 
100- fold reduction in RNA accumulation, consistent with 
the lower yield of virus following transfection of IVT viral 
RNA, and D148Q.A150E a more modest 2- fold reduction in 
RNA accumulation. A150V and P156A led to slight (less than 
1.5- fold) but consistent increases in viral RNA accumulation.
One of our main objectives in the study was to examine 
whether A150V, which is associated with host IFNL4 geno-
type, would affect multicycle HCV replication in the presence 
or absence of IFNλ4 using an in vitro model system. We have 
previously established a system to test the antiviral activity 
of WT human IFNλ4 in cases of HCV infection using 
conditioned media (CM) that contained IFNλ4 secreted by 
cells transfected with a plasmid expressing the protein [11]. 
Using the same approach, our prior study also examined the 
impact of IFNλ3 on infection, which demonstrated that it 
had a far greater antiviral effect. In the following experiments, 
we utilized CM containing IFNλ3 to determine the maximal 
impact of IFNλ proteins on HCV RNA replication and infec-
tion, but not as a comparison between IFNλ3 and IFNλ4 in 
these systems. Moreover, to determine the impact of IFNλ4 
on viral RNA replication and virus infection, we utilized 
maximal amounts of CM containing IFNλ4 that would not 
induce toxic effects.
Huh7 cells, treated with exogenous transfected- cell CM 
containing IFNs, were transfected with WT and mutant SGR 
RNAs or infected with WT and mutant HCVcc; GLuc activity 
was assayed at 48 h post- transfection (for SGR) and viral RNA 
measured at 72 h post- infection (for HCVcc). Given the low 
replication of SGR and HCVcc constructs carrying the D148A 
mutation, we excluded these constructs from further analysis. 
As expected, pre- treatment of Huh7 cells with exogenous 
IFNλs gave a greater reduction with IFNλ3 compared to 
IFNλ4 for Gluc activity from SGR (Fig. 2c, d) and viral RNA 
from HCVcc constructs (Fig. 2) compared to cells treated 
with a control CM from EGFP plasmid- transfected controls. 
These results were similar to those in our previous analyses 
[11]. SGRs containing mutations had reduced replication in 
EGFP- CM- treated cells compared to WT (Fig. 2c), consistent 
with the data presented in Fig. 2a at 48 h post- transfection 
(Fig. 2a). IFNλ pre- treatment inhibited SGR replication and, 
by normalizing the data to those from EGFP CM- treated cells, 
the mutations introduced into the SGR had a modest effect on 
replication in IFNλ4- treated cells, with all mutants yielding 
approximately ~1.5- fold higher Gluc levels compared to the 
WT construct treated with IFNλ4 (Fig. 2d). In the case of 
the P156A mutation, this higher level of replication in the 
presence of IFNλ4 achieved statistical significance (Fig. 2d). 
Similar to the data in Fig.  2b, the HCVcc D148Q.A150E 
mutant had reduced replication in EGFP- CM- treated cells 
compared to WT (Fig.  2e). IFNλ pre- treatment inhibited 
HCVcc RNA synthesis and, from normalization with EGFP 
CM- treated cells, showed that the D148Q.A150V mutant led 
to similar RNA accumulation to that of the WT construct 
(Fig.  2f). However, the A150V and P156A substitutions 
yielded a ~1.5- fold increase in RNA levels, similar to what was 
observed in SGR assays, achieving statistical significance in 
the case of A150V (Fig. 2f), suggestive of a consistently lower 
reduction in replication compared to the WT construct in the 
context of prior IFNλ4 treatment. We conclude that in the 
presence of exogenous IFNλ4, viral replication is modestly 
elevated for the A150V and P156A variants, located in the 
L2 loop in NS5B.
All of the variants introduced into the L2 loop and F2 region 
in the replicon and infectious systems were natural polymor-
phisms that occur in at least one HCV subtype (Fig. 1c). Since 
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Fig. 2. Effect of IFNL4- associated variants in the NS5B L2 loop on viral RNA replication in the presence and absence of IFNλ proteins. (a) 
Gluc activity at 4, 24, 48 and 72 h post- transfection of Huh7 cells with in vitro- transcribed SGR RNA. SGR constructs used are indicated 
and include a replication- incompetent GND control. Data are shown relative (%) to the 4 h Gluc activity for each construct (n=5). (b) 
TCID
50
 values for HCVcc harvested at 72 h following electroporation of IVT viral RNA (shown in grey). The graph also shows viral genomic 
RNA abundance (shown in black) at 72h post- infection following infection of Huh7 cells at a, m.o.i. of 0.01 with the indicated WT and 
mutant HCVcc viruses. Data for viral genomic RNA abundance are shown relative to WT HCVcc RNA, which were normalized to 1 (n=2). 
(c–f) Sensitivity of WT and mutant SGRs (c, d) or HCVcc (e, f) to addition of exogenous IFNλ3 and IFNλ4 compared to an EGFP control. 
Gluc activity (c, d) or HCV genome RNA abundance (e, f) at 48 h post- transfection of Huh7 cells with in vitro- transcribed SGR RNA or 
72h post- infection following infection with HCVcc (m.o.i. of 0.01) following treatment (24 h) with IFNλ3- or IFNλ4 CM (1 : 4) as well as the 
EGFP- negative control CM. Data shown relative to WT SGR RNA/HCVcc from EGFP- treated cells (c, e) or to each construct EGFP- treated 
control (d, f) normalized to ‘1’ (n=2). Abundance of viral genomic RNA was measured at 72 h post- infection relative to GAPDH mRNA. 
All data show mean (+/− standard error or the mean). Statistical significance was measured using a two- tailed Student’s t- test with * 
indicating P =>0.05.
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they were natural variants, we expected that they might have 
modest effects on viral RNA replication and virion produc-
tion. However, we observed a substantial drop in viral RNA 
levels at earlier times in the replicon assay and poor yields 
of virus for the D148A substitution. An alanine residue is 
only found at position 148 for gt1l, a rare subtype that is 
typically found in sub- Saharan Africa. By contrast, replacing 
both residues at positions 148 and 150 recreated the most 
frequently found amino acids in gt1a (D148Q.A150E) and 
replication was decreased by <twofold. Moreover, the other 
variants that were studied (A150V and P156A) had no overall 
effect on replication in the SGR system when compared to 
the WT construct and indeed gave a modest increase in viral 
RNA in the infectious model. Therefore, except for D148A, 
the substitutions were well tolerated in NS5B.
Recent molecular dynamics data have provided greater insight 
into the likely function of the HCV F domain in organizing 
the entry of nucleotides for access to the active site as well as 
the exit of pyrophosphate during the replication process [12]. 
Prior to nucleotide access to the active site, the F domain 
coordinates nucleotide reorientation and base stabilization 
through rearrangement of salt bridge interactions involving 
K151 (with either D352 or D387 depending on conformation) 
and R158 (with E143). The other residues comprising the F1–
L2–F2 region are likely to provide functional properties, such 
as coordinating the opening/closure of the nucleotide tunnel, 
structural flexibility and perhaps some nucleotide selectivity. 
Furthermore, a K151R mutation rescued infectivity of a P7 
mutant HCVcc but had no measurable effect on replication or 
NS5B activity in vitro [13]. Another study identified a poten-
tial interaction between the L2 loop and domain II of NS5A 
[14]. Thus, the L2 loop may participate in interactions with 
other regions of NS5B (for RNA replication) and with other 
viral proteins such as NS5A and P7/NS2 (e.g. for assembly). 
Both D148 and A150 are located on the surface of L2, facing 
downwards towards incoming nucleotides. These residues lie 
immediately to the N- terminal side of residue K151, which 
is nearly completely invariant and forms a critical salt bridge 
with D352, bisecting the nucleotide entry site in the closed 
conformation of the L2 loop. The presence of variant amino 
acid residues immediately upstream of K151 could have 
modulatory effects on the behaviour of the L2 loop. Clearly, 
from our data, the D148A substitution has a substantial 
impact on viral replication, suggesting that it impairs the 
function of the L2 loop in the context of the HCVgt2a strain 
JFH1/Jc-1. The effect of D148A on replication in the SGR 
system was only apparent at early times post- transfection 
of subgenomic viral RNA and, by 72 h, RNA replication 
was indistinguishable from that of the WT construct. The 
differences observed at 72 h between the SGR and infec-
tious assays (compare Fig. 2a, b) may reflect the multi- cycle 
nature of infection with the JFH1/Jc-1 system. Alternatively, 
D148A could influence not only viral RNA replication, but 
also virion assembly. By contrast, both double variants at 
positions 148 and 150 (D148Q.A150E) and a single variant 
at position 150 (A150V) are well tolerated. Thus, it is possible 
to introduce intragenotypic and intergenotypic substitutions 
into L2 without disrupting function. This indicates a degree of 
redundancy in the L2 loop sequences. However, it is possible 
that certain variants have subtle effects on the selectivity of 
incoming nucleotides. For example, the A150V variant gave 
reduced susceptibility to the nucleotide analogue sofosbuvir, 
which is a clinically approved and highly potent direct- acting 
antiviral [15]. This reduced potency could arise from lower 
capacity of the A150V substitution to allow sofosbuvir entry 
into the catalytic site of the polymerase. Furthermore, we see 
differences between the HCV subgenomic replicon and infec-
tious virus assays for A150V (and P156A), such that these 
mutations affect viral replication in the replicon but not the 
HCVcc system. This may suggest differing roles of these sites 
in replication compared to assembly.
Our data reveal that mutations A150V and P156A influ-
ence viral replication in the presence of exogenous IFNλ4, 
such that, for both variants, the reduction in replication was 
lower in both SGR and HCVcc systems compared to the WT 
control. These results suggest that V150 and A156 confer 
slight resistance to IFNλ4. The higher prevalence for V150 
in those with IFNL4 alleles that produce functional protein 
would suggest a fitness advantage for this variant, which may 
be consistent with the partial IFNλ4 resistance observed in 
our assays. However, viral load is lower in chronic infection 
in individuals who have IFNL4 alleles that produce IFNλ4 
compared to those who fail to make functional protein [2, 3]. 
Thus, our data illustrate the challenge with aligning in vitro 
results to understand the mechanisms underlying in vivo 
findings. It is possible that there are epistatic effects, which 
would be difficult to ascertain with in vitro methods that do 
not recapitulate infection by natural strains. In conclusion, we 
have characterized the replicative effects of variants associated 
with the IFNL4 genotype that could serve as the basis for 
further studies on the role of viral variability in physiologi-
cally relevant in vitro models.
Funding information
This work was supported by the UK Medical Research Council 
(MC_UU_12014/1).
Acknowledgements
We wish to thank undergraduate students Maria Chalmers and Aqsa 
Sharif for their help with this project.
Author contributions
C. B. and J. M. conceived the project and established the goals of the 
study; C. B. conducted all experiments; C. B. and J. M. analysed and 
interpreted the data; C. B. and J. M. were responsible for writing and 
preparing the manuscript.
Conflicts of interest
The authors declare that there are no conflicts of interest.
References
 1. Prokunina- Olsson L, Muchmore B, Tang W, Pfeiffer RM, Park H 
et al. A variant upstream of IFNL3 (IL28B) creating a new interferon 
gene IFNL4 is associated with impaired clearance of hepatitis C 
virus. Nat Genet 2013;45:164–171.
 2.  Ansari MA, Pedergnana V, L C Ip C, Magri A, Von Delft A et  al. 
Genome- to- genome analysis highlights the effect of the human 
innate and adaptive immune systems on the hepatitis C virus. Nat 
Genet 2017;49:666–673.
6
Bamford and McLauchlan, Journal of General Virology 2021;102:001495
 3.  Ansari MA, Aranday- Cortes E, Ip CLC, da Silva Filipe A, Lau SH 
et al. Interferon lambda 4 impacts the genetic diversity of hepatitis 
C virus. eLife 2019;8:e42463.
 4.  Chaturvedi N, Svarovskaia ES, Mo H, Osinusi AO, Brainard DM et al. 
Adaptation of hepatitis C virus to interferon lambda polymorphism 
across multiple viral genotypes. eLife 2019;8:e42542.
 5. Selisko B, Papageorgiou N, Ferron F, Canard B. Structural and 
functional basis of the fidelity of nucleotide selection by flavivirus 
RNA- dependent RNA polymerases. Viruses 2018;10:59.
 6. Bressanelli S, Tomei L, Roussel A, Incitti I, Vitale RL et al. Crystal 
structure of the RNA- dependent RNA polymerase of hepatitis C 
virus. Proc Natl Acad Sci U S A 1999;96:13034–13039.
 7. Domingues P, Bamford CGG, Boutell C, McLauchlan J. Inhibition 
of hepatitis C virus RNA replication by ISG15 does not require its 
conjugation to protein substrates by the HERC5 E3 ligase. J Gen 
Virol 2015;96:3236–3242.
 8.  Pietschmann T, Kaul A, Koutsoudakis G, Shavinskaya A, Kallis S 
et  al. Construction and characterization of infectious intrageno-
typic and intergenotypic hepatitis C virus chimeras. Proc Natl Acad 
Sci USA 2006;103:7408–7413.
 9. Rose R, Markov PV, Lam TT, Pybus OG. Viral evolution explains the 
associations among hepatitis C virus genotype, clinical outcomes, 
and human genetic variation. Infect Genet Evol 2013;20:418–421.
 10. Lindenbach BD, Meuleman P, Ploss A, Vanwolleghem T, 
Syder AJ et  al. Cell culture- grown hepatitis C virus is infectious 
in vivo and can be recultured in vitro. Proc Natl Acad Sci U S A 
2006;103:3805–3809.
 11. Bamford CGG, Aranday- Cortes E, Filipe IC, Sukumar S, Mair D 
et  al. A polymorphic residue that attenuates the antiviral poten-
tial of interferon lambda 4 in hominid lineages. PLoS Pathog 
2018;14:e1007307.
 12. Ben Ouirane K, Boulard Y, Bressanelli S. The hepatitis C virus RNA- 
dependent RNA polymerase directs incoming nucleotides to its 
active site through magnesium- dependent dynamics within its F 
motif. J Biol Chem 2019;294:7573–7587.
 13.  Gouklani H, Bull RA, Beyer C, Coulibaly F, Gowans EJ et al. Hepa-
titis C virus nonstructural protein 5B is involved in virus morpho-
genesis. J Virol 2012;86:5080–5088.
 14.  Dujardin M, Cantrelle F- X, Lippens G, Hanoulle X. Interaction study 
between HCV NS5A- D2 and NS5B using 19F NMR. J Biomol NMR 
2018;70:67–76.
 15. Wing PAC, Jones M, Cheung M, DaSilva S, Bamford C et  al. 
Amino acid substitutions in genotype 3A hepatitis C virus poly-
merase protein affect responses to sofosbuvir. Gastroenterology 
2019;157:692–704.
Five reasons to publish your next article with a Microbiology Society journal
1.  The Microbiology Society is a not-for-profit organization.
2.  We offer fast and rigorous peer review – average time to first decision is 4–6 weeks.
3.   Our journals have a global readership with subscriptions held in research institutions around  
the world.
4.  80% of our authors rate our submission process as ‘excellent’ or ‘very good’.
5.  Your article will be published on an interactive journal platform with advanced metrics.
Find out more and submit your article at microbiologyresearch.org.
